The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.

The U.S. Food and Drug Administration announced this week it has authorized the marketing of three new tobacco products, CNN reports. R.J. Reynolds will be allowed to sell three of its Vuse vape products.
A new study finds 20% of surgical patients who start taking prescription opioids after their procedure continue to take them three months after surgery.
College students who misuse prescription stimulant medications such as Adderall or Ritalin in an attempt to focus better while studying are at increased risk of misusing other substances including alcohol and marijuana, new research finds.
Find more of our must-reads in policy news, including the FDA's first vaping product authorization.
View our curated digest of the latest research news, including the efficacy of a web-based treatment tool designed to identify substance use treatment centers.
A new study suggests people with substance use disorders may be at increased risk for breakthrough COVID-19 cases, HealthDay reports.
The trial against four pharmacy chains over their role in the opioid crisis began on Monday, the Associated Press reports.
More than 2 million U.S. middle school and high school students say they currently use e-cigarettes, according to a new report by the Centers for Disease Control and Prevention.
Find more of our must-reads in policy news, including the start of an opioid trial against CVS, Walgreens, Giant Eagle and Walmart.
View our curated digest of the latest research news, including the impact of e-cigarette flavors on youth.
Overdose deaths involving methamphetamine almost tripled in the United States between 2015 and 2019, according to a new study.
The Drug Enforcement Administration has issued a warning about an increase in counterfeit pills laced with fentanyl that are made to look like real prescription medications.
Almost one in five high school students uses e-cigarettes, cigarettes and marijuana together, according to a new study.
Find more of our must-reads in policy news, including a DEA public safety alert on pills laced with fentanyl and methamphetamine.
View our curated digest of the latest research news, including the argument that substance addiction is a brain disease.
Over the last decade, doctors prescribed 44% fewer opioids, yet opioid overdoses continued to rise, a new report from the American Medical Association finds.
California’s state attorney general has approved signature gathering for a proposed ballot initiative that would decriminalize the psychedelic drug psilocybin, the psychoactive compound found in “magic mushrooms.”
The animal tranquilizer xylazine has been linked to a growing number of overdose deaths around the country, HealthDay reports.
Find more of our must-reads in policy news, including a report from the American Medical Association with new recommendations to address increasing opioid overdose rates.
View our curated digest of the latest research news, including the effects of prenatal environmental tobacco smoke exposure.
Daily marijuana use among college students reached an all-time high last year, according to the annual Monitoring the Future study.
Opioid overdose deaths increased 38% among non-Hispanic Black Americans from 2018 to 2019, a new study finds. In contrast, opioid overdose deaths remained about the same among other race and ethnicity groups, HealthDay reports.
The Food and Drug Administration announced it was delaying a decision about whether to allow Juul e-cigarettes to stay on the market, the Associated Press reports. The agency said it had rejected applications for almost 950,000 other e-cigarettes and related products, because of their potential to appeal to minors.
Find more of our must-reads in policy news, including a delayed FDA decision that could dictate the future of e-cigarette giant Juul.
View our curated digest of the latest research news, including the use of naltrexone in the treatment of alcohol use disorder.